Cargando…

Editorial: Hepatic immune response underlying liver cirrhosis and portal hypertension

Detalles Bibliográficos
Autores principales:	Guo, Yangkun, Ma, Xiong, Nie, Yongzhan, Kostallari, Enis, Gao, Jinhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034766/ https://www.ncbi.nlm.nih.gov/pubmed/36969230 http://dx.doi.org/10.3389/fimmu.2023.1174562

Ejemplares similares

Editorial: Community series in hepatic immune response underlying liver cirrhosis and portal hypertension, volume II
por: Lan, Tian, et al.
Publicado: (2023)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms, Volume II
por: Jerez, Sofia, et al.
Publicado: (2023)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms
por: Ye, Yanting, et al.
Publicado: (2022)

Editorial: Portal hypertension in cirrhosis and liver vascular diseases: from ethiopathogenesis to current strategies
por: Luo, Xuefeng, et al.
Publicado: (2023)

The gut–liver axis in immune remodeling of hepatic cirrhosis
por: Guan, Huayu, et al.
Publicado: (2022)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis
por: Guo, Qianqian, et al.
Publicado: (2022)

GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin Pathway
por: Yaqoob, Usman, et al.
Publicado: (2020)

Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis
por: Ren, Ao, et al.
Publicado: (2023)

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
por: Herath, Chandana B., et al.
Publicado: (2022)

Editorial: Reviews in gastroenterology
por: Lan, Tian, et al.
Publicado: (2023)

Portal Hypertensive Polyps as Gastroscopic Finding in Liver Cirrhosis
por: Topal, Firdevs, et al.
Publicado: (2020)

Hepatic-Associated Immunoglobulin-A Nephropathy in a Child with Liver Cirrhosis and Portal Hypertension
por: Alghamdi, Sharifa A., et al.
Publicado: (2012)

Hepatic Sarcoidosis Presenting as Portal Hypertension and Liver Cirrhosis: Case Report and Review of the Literature
por: Tan, Christopher B., et al.
Publicado: (2012)

Pulmonary hypertension in patients with hepatic cirrhosis and portal hypertension. An echographic study
por: GURGHEAN, ADRIANA V., et al.
Publicado: (2017)

The kidney in cirrhosis with portal hypertension
por: Olteanu, D, et al.
Publicado: (2010)

The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
por: Seo, Yeon Seok, et al.
Publicado: (2012)

Comment on “Hepatic-associated Immunoglobulin A Nephropathy in a Child with Liver Cirrhosis and Portal Hypertension”
por: Nasri, Hamid, et al.
Publicado: (2014)

Future therapy of portal hypertension in liver cirrhosis – a guess
por: Sauerbruch, Tilman, et al.
Publicado: (2014)

Portal Hypertensive Polyposis in Advanced Liver Cirrhosis: The Unknown Entity?
por: Kara, David, et al.
Publicado: (2018)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Hepatic Arterial Vasodilation Is Independent of Portal Hypertension in Early Stages of Cirrhosis
por: Moeller, Miriam, et al.
Publicado: (2015)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Advances and challenges in cirrhosis and portal hypertension
por: Berzigotti, Annalisa
Publicado: (2017)

Effect of Meal Ingestion on Liver Stiffness in Patients with Cirrhosis and Portal Hypertension
por: Berzigotti, Annalisa, et al.
Publicado: (2013)

Non-Invasive Diagnostic and Prognostic Evaluation of Liver Cirrhosis and Portal Hypertension
por: Berzigotti, Annalisa, et al.
Publicado: (2011)

Portal hypertensive gastropathy as a prognostic index in patients with liver cirrhosis
por: Bang, Chang Seok, et al.
Publicado: (2016)

Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2018)

The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis
por: Reiberger, Thomas
Publicado: (2021)

Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension
por: Paternostro, Rafael, et al.
Publicado: (2018)

Hepatitis C is now curable, but what happens with cirrhosis and portal hypertension afterwards?
por: Grgurevic, Ivica, et al.
Publicado: (2017)

An uncommon presentation of hepatic hydatid cyst leading to biliary cirrhosis and portal hypertension
por: Asadzadeh-Aghdaei, Hamid, et al.
Publicado: (2020)

Impact of sustained virologic response in regression of portal hypertension in Egyptian patients with hepatitis C virus-associated cirrhosis and portal hypertension
por: Faheem, Heba Ahmed, et al.
Publicado: (2022)

Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure
por: Jagdish, Rakesh Kumar, et al.
Publicado: (2023)

Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis
por: Gan, Can, et al.
Publicado: (2022)

Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress
por: Tai, Yang, et al.
Publicado: (2021)

Extrapulmonary Sarcoidosis Manifested as Cirrhosis with Portal Hypertension
por: Kothakota, Sunil Raviraj, et al.
Publicado: (2021)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
por: Lim, Yoo Li, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6tf19mjmlh3n24iies7dpp8db5